Novavax, Inc. (NVAX) Earnings Call Analysis
NASDAQ · Healthcare · Biotechnology
Next earnings call: 2026-08-06
(Q2 2026)
— full calendar
Earnings Reports
-
Novavax (NVAX) Q1 2026: Partner Revenue Surges 116% as MatrixM Adoption Accelerates
May 06, 2026
-
Novavax (NVAX) Q4 2025: R&D and SG&A Spend Slashed 53% as Matrix-M Partnerships Accelerate
February 26, 2026
-
Novavax (NVAX) Q3 2025: Sanofi Milestones Hit $225M as Platform Pivot Redefines Path to Profitability
November 06, 2025
-
Novavax (NVAX) Q2 2025: $175M Sanofi Milestone Triggers Leaner Model and Partnership Leverage
August 06, 2025
-
Novavax (NVAX) Q1 2025: Cost Base Down 24%, Platform Partnerships Expand as Revenue Framework Rises
July 07, 2025